| Price | 9.00p on 24-04-2026 at 10:00:19 |
|---|---|
| Change | -0.15p -1.64% |
| Buy | 9.20p |
| Sell | 8.80p |
| Last Trade: | Sell 25,000.00 at 8.83p |
| Day's Volume: | 320,682 |
| Last Close: | 9.15p |
| Open: | 9.05p |
| ISIN: | GB00BYV81293 |
| Day's Range | 9.00p - 9.05p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £96.16m |
| VWAP: | 8.93449p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 25,000 | 8.83p | Ordinary |
10:27:10 - 24-Apr-26 |
| Sell* | 10,000 | 8.84p | Ordinary |
10:14:36 - 24-Apr-26 |
| Buy* | 5,762 | 9.198p | Ordinary |
08:49:06 - 24-Apr-26 |
| Sell* | 1,505 | 8.80p | SI Trade |
08:47:33 - 24-Apr-26 |
| Buy* | 32 | 9.20p | SI Trade |
08:47:33 - 24-Apr-26 |
| Buy* | 13 | 9.20p | SI Trade |
08:47:33 - 24-Apr-26 |
| Buy* | 16 | 9.20p | SI Trade |
08:47:33 - 24-Apr-26 |
| Buy* | 32 | 9.20p | SI Trade |
08:47:33 - 24-Apr-26 |
| Sell* | 56,668 | 8.85p | Ordinary |
08:47:14 - 24-Apr-26 |
| Sell* | 63,289 | 9.00p | Ordinary |
08:36:45 - 24-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
